Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW 3,725.00
+115.00 (3.19%)
Apr 1, 2025, 3:30 PM KST
Xcell Therapeutics Revenue
In the year 2024, Xcell Therapeutics had annual revenue of 1.93B KRW with 72.11% growth. Xcell Therapeutics had revenue of 476.51M in the quarter ending December 31, 2024, a decrease of -2.22%.
Revenue
1.93B
Revenue Growth
+72.11%
P/S Ratio
19.26
Revenue / Employee
n/a
Employees
61
Market Cap
40.75B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |